Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 114Carcinoma, Non-Small-Cell Lung 34Neoplasms 26Neoplasm Metastasis 19Prostatic Neoplasms 18Uveal Melanoma 16Carcinoma, Renal Cell 16Lung Neoplasms 14Pancreatic Neoplasms 13Diabetes Mellitus, Insulin-Dependent, 12 12Small Cell Lung Carcinoma 11Colorectal Neoplasms 10Carcinoma, Hepatocellular 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Breast Neoplasms 8Sarcoma 7Carcinoma, Transitional Cell 7Brain Neoplasms 7Stomach Neoplasms 6Mesothelioma 6Kidney Neoplasms 6Head and Neck Neoplasms 6Advanced Cancer 6Urinary Bladder Neoplasms 5Recurrence 5Ovarian Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma 5Leukemia, Myeloid, Acute 5

Interventions

Radiotherapy 16Amifostine 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Paclitaxel 4Donepezil 4sargramostim 3Radiosurgery 3Low-Level Light Therapy 3Filgrastim 3Etoposide 3Carboplatin 3Surveys and Questionnaires 2Radiation 2Magnetic Resonance Spectroscopy 2Esophagectomy 2Diet Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2Bevacizumab 2olaparib 1ethanethiol 1delta 24-sterol reductase 1cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vitamin E 1Vincristine 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Radiation Injuries × Ipilimumab × Clear all
NCT02406183 2017-01-10

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

University Hospital, Ghent

Phase 1 Completed
13 enrolled
Dermatologic

Melanoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡